{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T02:49:51Z","timestamp":1771123791314,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.rdc.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T19:29:25Z","timestamp":1667330965000},"page":"845-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Environmental Risks for Systemic Sclerosis"],"prefix":"10.1016","volume":"48","author":[{"given":"Hana","family":"Alahmari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zareen","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rdc.2022.06.006_bib1","first-page":"1117","article-title":"Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases","volume":"33","author":"Johnson","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2022.06.006_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.140006","article-title":"The effect of male sex on survival in systemic sclerosis","volume":"41","author":"Hussein","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2022.06.006_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-016-0933-1","article-title":"Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study","volume":"18","author":"Pasarikovski","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.rdc.2022.06.006_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3899\/jrheum.180042","article-title":"Ethnic variations in systemic sclerosis disease manifestations, internal organ involvement, and mortality","volume":"46","author":"Al-Sheikh","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2022.06.006_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/jrheum.080915","article-title":"Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis","volume":"36","author":"Low","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.006_bib6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3899\/jrheum.170953","article-title":"Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome","volume":"45","author":"Alharbi","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/annrheumdis-2021-219884","article-title":"Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes","volume":"80","author":"Acosta-Herrera","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2022.06.006_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.006_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/BOR.0b013e328358575b","article-title":"The genetics of scleroderma: looking into the postgenomic era","volume":"24","author":"Mayes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2022.06.006_bib10","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2022.06.006_bib11","doi-asserted-by":"crossref","first-page":"102727","DOI":"10.1016\/j.jaut.2021.102727","article-title":"Insights into the knowledge of complex diseases: Environmental infectious\/toxic agents as potential etiopathogenetic factors of systemic sclerosis","volume":"124","author":"Ferri","year":"2021","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.006_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-020-04693-3","article-title":"Is exposure to environmental factors associated with a characteristic clinical and laboratory profile in systemic sclerosis? A retrospective analysis","volume":"41","author":"Aguila","year":"2021","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.rdc.2022.06.006_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","article-title":"Occupational silica exposure as a risk factor for scleroderma: a meta-analysis","volume":"83","author":"McCormic","year":"2010","journal-title":"Int Arch Occup Environ Health"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.006_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00000637-199512000-00001","article-title":"A\u00a0meta-analysis of breast implants and connective tissue disease","volume":"35","author":"Perkins","year":"1995","journal-title":"Ann Plast Surg"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1203475420957950","article-title":"Toward Understanding of Environmental Risk Factors in Systemic Sclerosis","volume":"25","author":"Ouchene","year":"2021","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-015-0504-6","article-title":"Epigenetics and systemic sclerosis","volume":"37","author":"Altorok","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","article-title":"Systemic sclerosis and exposure to heavy metals","volume":"18","author":"Marie","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.rdc.2022.06.006_bib19","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.090207","article-title":"Systemic sclerosis: environmental factors","volume":"36","author":"Mora","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2022.06.006_bib20","first-page":"838","article-title":"Silica, silicosis, and progressive systemic sclerosis","volume":"42","author":"Sluis-Cremer","year":"1985","journal-title":"Br J Ind Med"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-66-2-323","article-title":"The association of progressive systemic sclerosis (Scleroderma) with Coal Miners' pneumoconiosis and other forms of silicosis","volume":"66","author":"Rodnan","year":"1967","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-4362.1985.tb05745.x","article-title":"Environmentally induced systemic sclerosis-like disorders","volume":"24","author":"Haustein","year":"1985","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib23","doi-asserted-by":"crossref","first-page":"rky041","DOI":"10.1093\/rap\/rky041","article-title":"Risk factors for the development of systemic sclerosis: a systematic review of the literature","volume":"2","author":"Abbot","year":"2018","journal-title":"Rheumatol Adv Pract"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1445-5994.2000.tb00810.x","article-title":"Male systemic sclerosis and occupational silica exposure-a population-based study","volume":"30","author":"Englert","year":"2000","journal-title":"Aust N Z J Med"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10067-009-1371-0","article-title":"Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons","volume":"29","author":"Slimani","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/08958370490270936","article-title":"Immunoglobulin and lymphocyte responses following silica exposure in New Zealand Mixed mice","volume":"16","author":"Brown","year":"2004","journal-title":"Inhalation Toxicol"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.semarthrit.2018.06.009","article-title":"High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes","volume":"48","author":"Ferri","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00296-015-3412-0","article-title":"Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort","volume":"36","author":"Rocha","year":"2016","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/rtph.1996.0011","article-title":"A\u00a0critical assessment of the relationship between silicone breast implants and connective tissue diseases","volume":"23","author":"Wong","year":"1996","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib30","first-page":"159","article-title":"Scleroderma and silicone breast implants","volume":"167","author":"Whorton","year":"1997","journal-title":"West J Med"},{"issue":"11","key":"10.1016\/j.rdc.2022.06.006_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM200003163421105","article-title":"Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases","volume":"342","author":"Janowsky","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajim.1098","article-title":"Meta-analysis of systemic sclerosis and exposure to solvents","volume":"40","author":"Aryal","year":"2001","journal-title":"Am J Ind Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib33","first-page":"97","article-title":"Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies","volume":"34","author":"Kettaneh","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/RHU.0000000000000354","article-title":"The influence of different solvents on systemic sclerosis: an updated meta-analysis of 14 case-control studies","volume":"22","author":"Zhao","year":"2016","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0162-3109(99)00164-2","article-title":"Trichloroethylene accelerates an autoimmune response by Th1 T\u00a0cell activation in MRL+\/+ mice","volume":"46","author":"Griffin","year":"2000","journal-title":"Immunopharmacology"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000250328","article-title":"Occupational scleroderma-like disorder occurring in men engaged in the polymerization of epoxy resins","volume":"161","author":"Yamakage","year":"1980","journal-title":"Dermatologica"},{"issue":"12","key":"10.1016\/j.rdc.2022.06.006_bib37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.51.12.1322","article-title":"What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?","volume":"51","author":"Silman","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/oem.59.8.545","article-title":"Systemic sclerosis and occupational risk factors: a case-control study","volume":"59","author":"Diot","year":"2002","journal-title":"Occup Environ Med"},{"issue":"15","key":"10.1016\/j.rdc.2022.06.006_bib40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/15287394.2018.1485124","article-title":"Case series: rheumatological manifestations attributed to exposure to Libby Asbestiform Amphiboles","volume":"81","author":"Diegel","year":"2018","journal-title":"J\u00a0Toxicol Environ Health A"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib41","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1289\/ehp.9203","article-title":"Nested case-control study of autoimmune disease in an asbestos-exposed population","volume":"114","author":"Noonan","year":"2006","journal-title":"Environ Health Perspect"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.006_bib42","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/art.22880","article-title":"Systemic autoimmune disease mortality and occupational exposures","volume":"56","author":"Gold","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0304-4165(80)90309-8","article-title":"Bleomycin-induced synthesis of type I procollagen by human lung and skin fibroblasts in culture","volume":"631","author":"Clark","year":"1980","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1346-8138.2011.01301.x","article-title":"Case of bleomycin-induced scleroderma","volume":"39","author":"INAOKI","year":"2012","journal-title":"J\u00a0Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ijd.12437","article-title":"Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis","volume":"55","author":"Winkelmann","year":"2016","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1078::AID-CNCR19>3.0.CO;2-T","article-title":"Cutaneous fibrosis induced by docetaxel: a case report","volume":"88","author":"Cleveland","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib48","doi-asserted-by":"crossref","first-page":"102439","DOI":"10.1016\/j.autrev.2019.102439","article-title":"Systemic sclerosis induced by CNS stimulants for ADHD: a case series and review of the literature","volume":"19","author":"Meridor","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib49","first-page":"294","article-title":"Scleroderma in association with the use of bleomycin: a report of 3 cases","volume":"19","author":"Kerr","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2022.06.006_bib50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/ijd.14067","article-title":"Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature","volume":"57","author":"Verhulst","year":"2018","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.2004.01668.x","article-title":"Chemotherapy-induced scleroderma: a pleiomorphic syndrome","volume":"30","author":"Alexandrescu","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"13","key":"10.1016\/j.rdc.2022.06.006_bib52","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199003293221302","article-title":"Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan","volume":"322","author":"Silver","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.rdc.2022.06.006_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM198010023031403","article-title":"Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa","volume":"303","author":"Sternberg","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2022.06.006_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5606\/ArchRheumatol.2014.3429","article-title":"Letrozole-induced very early systemic sclerosis in a patient with breast cancer: a case report","volume":"29","author":"Pokhai","year":"2014","journal-title":"Arch Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib55","first-page":"254","article-title":"Systemic sclerosis after therapy with appetite suppressants","volume":"11","author":"Tomlinson","year":"1984","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0190-9622(80)80292-1","article-title":"Skin manifestations of pentazocine abuse","volume":"2","author":"Palestine","year":"1980","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2133.2005.06708.x","article-title":"Methysergide-induced scleroderma-like changes of the legs","volume":"153","author":"Kluger","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-4362.1989.tb02457.x","article-title":"Morphea after bromocriptine therapy","volume":"28","author":"Leshin","year":"1989","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib59","doi-asserted-by":"crossref","first-page":"102596","DOI":"10.1016\/j.autrev.2020.102596","article-title":"Risk of scleroderma according to the type of immune checkpoint inhibitors","volume":"19","author":"Terrier","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib60","first-page":"263","article-title":"Systemic sclerosis induced by interferon-alfa treatment of melanoma","volume":"42","author":"Silva","year":"2017","journal-title":"Acta Reumatologica Portuguesa"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12026-016-8851-5","article-title":"Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases","volume":"65","author":"Balbi","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1440-0960.1996.tb00994.x","article-title":"Pseudoscleroderma secondary to phytomenadione (vitamin K1) injections: Texier's disease","volume":"37","author":"Pang","year":"1996","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0961203311429317","article-title":"Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome)","volume":"21","author":"Vera-Lastra","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2022.06.006_bib64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D336K88174","article-title":"Linear scleroderma after contusion and injection of mepivacaine hydrochloride","volume":"16","author":"Ueda","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.rdc.2022.06.006_bib65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.13075\/mp.5893.00260","article-title":"Can scleroderma be induced by anesthetics? Case report","volume":"6","author":"Magnavita","year":"2016","journal-title":"Med Pr"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00442147","article-title":"Familial occurrence of dermatomyositis and progressive scleroderma after injection of a local anaesthetic for dental treatment","volume":"143","author":"Rose","year":"1985","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00296-018-4227-6","article-title":"Systemic sclerosis induced by the use of cocaine: is there an association?","volume":"39","author":"Andreussi","year":"2019","journal-title":"Rheumatol Int"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2022.06.006_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","article-title":"Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology","volume":"79","author":"Sternb\u00e6k","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","article-title":"Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes","volume":"19","author":"Farina","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.006_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.61.10.937","article-title":"Systemic sclerosis following human cytomegalovirus infection","volume":"61","author":"Ferri","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.006_bib71","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/microorganisms8010039","article-title":"HHV-6A infection and systemic sclerosis: clues of a possible association","volume":"8","author":"Caselli","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib73","doi-asserted-by":"crossref","first-page":"17683","DOI":"10.1038\/s41598-018-36146-0","article-title":"Human Herpesvirus 6A and 6B inhibit in\u00a0vitro angiogenesis by induction of Human Leukocyte Antigen G","volume":"8","author":"Rizzo","year":"2018","journal-title":"Scientific Rep"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib74","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/cells10051060","article-title":"Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis","volume":"10","author":"Soffritti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.rdc.2022.06.006_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clim.2019.07.012","article-title":"A\u00a0comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis","volume":"207","author":"Efthymiou","year":"2019","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib76","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.10346","article-title":"Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et\u00a0al","volume":"46","author":"Ferri","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2005.05.003","article-title":"Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures","volume":"114","author":"Zakrzewska","year":"2005","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.006_bib78","first-page":"718","article-title":"Parvovirus B19 infection of bone marrow in systemic sclerosis patients","volume":"17","author":"Ferri","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2022.06.006_bib79","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jid.2019.03.1144","article-title":"Effects of Parvovirus B19 In\u00a0Vitro Infection on Monocytes from Patients with Systemic Sclerosis: Enhanced Inflammatory Pathways by Caspase-1 Activation and Cytokine Production","volume":"139","author":"Zakrzewska","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2\u20134","key":"10.1016\/j.rdc.2022.06.006_bib80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/08830189509056710","article-title":"Retroviruses and the Pathogenesis of Systemic Sclerosis","volume":"12","author":"Jimenez","year":"1995","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2022.06.006_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0092-8674(87)90148-6","article-title":"A\u00a0human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen","volume":"51","author":"Query","year":"1987","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib82","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/BOR.0000000000000623","article-title":"The association between hepatitis B, hepatitis C and systemic sclerosis: a cross-sectional study","volume":"31","author":"Tiosano","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2022.06.006_bib83","doi-asserted-by":"crossref","first-page":"e13887","DOI":"10.1111\/ijcp.13887","article-title":"Association of human papillomavirus and systemic sclerosis: a population based cohort study","volume":"75","author":"Chen","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.rdc.2022.06.006_bib84","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00442996","article-title":"Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis","volume":"136","author":"Urano","year":"1981","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rdc.2022.06.006_bib85","first-page":"681","article-title":"Localized scleroderma after infection with Epstein-Barr virus","volume":"11 6","author":"Longo","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2022.06.006_bib86","doi-asserted-by":"crossref","first-page":"e13123","DOI":"10.1111\/eci.13123","article-title":"Chronic Q fever associated with systemic sclerosis","volume":"49","author":"Jansen","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rdc.2022.06.006_bib87","doi-asserted-by":"crossref","first-page":"686699","DOI":"10.3389\/fimmu.2021.686699","article-title":"Case Report: Systemic Sclerosis After Covid-19 Infection","volume":"12","author":"Fineschi","year":"2021","journal-title":"Front Immunol"},{"issue":"Suppl 113","key":"10.1016\/j.rdc.2022.06.006_bib88","first-page":"168","article-title":"Helicobacter pylori infection in systemic sclerosis: a systematic review and meta-analysis of observational studies","volume":"36","author":"Yong","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1346-8138.2007.00405.x","article-title":"Coincidental association of mycosis fungoides and occupational systemic sclerosis?","volume":"35","author":"Yasuda","year":"2008","journal-title":"J\u00a0Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib90","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1749-6632.2009.04808.x","article-title":"The Role of Infections in the Immunopathogensis of Systemic Sclerosis\u2013Evidence from Serological Studies","volume":"1173","author":"Arnson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib91","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/jid.2014.127","article-title":"High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis","volume":"134","author":"Arron","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2022.06.006_bib92","first-page":"250","article-title":"Helicobacter pylori Infection in Connective Tissue Disorders is Associated with High Levels of Antibodies to Mycobacterial hsp65 but not to Human hsp60","volume":"7","author":"Kalabay","year":"2002","journal-title":"Helicobacter (Cambridge, Mass)"},{"issue":"4","key":"10.1016\/j.rdc.2022.06.006_bib93","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.diagmicrobio.2009.04.005","article-title":"High prevalence of virulent Helicobacter pylori strains in symptomatic Bulgarian patients","volume":"64","author":"Boyanova","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.rdc.2022.06.006_bib94","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1023\/A:1018842527111","article-title":"Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon","volume":"43","author":"Gasbarrini","year":"1998","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.rdc.2022.06.006_bib95","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.39572","article-title":"Association of systemic sclerosis with a unique colonic microbial consortium","volume":"68","author":"Volkmann","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib96","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib97","doi-asserted-by":"crossref","first-page":"14874","DOI":"10.1038\/s41598-017-14889-6","article-title":"Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement","volume":"7","author":"Patrone","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13075-019-1816-z","article-title":"Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin","volume":"21","author":"Johnson","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2022.06.006_bib99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13075-019-1872-4","article-title":"Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis","volume":"21","author":"Denton","year":"2019","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:30:26Z","timestamp":1760182226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X22000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0889857X22000461"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2022.06.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental Risks for Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}